申请人:Pfizer Inc.
公开号:US08278457B2
公开(公告)日:2012-10-02
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I:
as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.
本发明涉及一类化合物,包括具有公式I结构的化合物的药用可接受盐,如规范中所定义的。本发明还涉及包含公式I化合物的组合物和其用途。